Skip to main content

Neurocrine Biosciences Inc

NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000914475

In the last 90 days, Neurocrine Biosciences Inc insiders filed 0 open-market purchases and 7 sales; 782 institutions reported holding it in 13F filings for Q2 2026, worth $17.0B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Neurocrine Biosciences Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
6 insiders, $6.24M in total
Insiders trading
6
Net value
−$6.24M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Neurocrine Biosciences Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Neurocrine Biosciences Inc
NameTitleLast reported holdingLast filingFilings, past year
Onyia JudeChief Scientific Officer22,647Sep 15, 20269
Lippoldt DarinChief Legal Officer56,793Sep 15, 20267
Keswani Sanjay ChandruChief Medical Officer3,281Sep 15, 20263
Gorman Kevin CharlesDirector517,797Sep 15, 20265
Gano KyleChief Executive Officer154,728Sep 15, 20265
Delaet IngridChief Regulatory Officer18,289Sep 15, 20266
Cooke JulieChief Human Resources Officer24,025Sep 15, 20264
Boyer David W.Chief Corp. Affairs Officer8,722Sep 15, 20264
Benevich EricChief Commercial Officer67,297Sep 15, 20265
Abernethy MattChief Financial Officer42,808Sep 15, 20264
Sherwin Stephen ADirector14,860Sep 3, 20264
Norwalk Leslie VDirector2,430Jul 30, 20266
Morrow George JDirector10,386May 29, 20263
Lyons Gary ADirector122,141May 29, 20263
Pops Richard FDirector37,798May 29, 20263
Poon Christine ADirector4,753May 29, 20262
Rastetter William HDirector43,678May 29, 20263
Sharp ShaliniDirector4,088May 29, 20262
Mercier JohannaDirector6,853May 29, 20262
Roberts EiryChief Medical Officer35,640Feb 14, 20250
Lloyd-Smith MalcolmChief Integration Officer42,337Feb 8, 20230
Grigoriadis Dimitri E.Chief Research Officer82,273Feb 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 2, 2024 (view filing)Jan 312 daysBenevich EricChief Commercial OfficerSSale−1.21K$140.78−$169.9K−3.1%37.6K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysBoyer David W.Chief Corp. Affairs OfficerSSale−2.10K$140.80−$295.1K−30.0%4.89K after2 lots10b5-1
Feb 2, 2024 (view filing)Jan 312 daysCooke JulieChief Human Resources OfficerSSale−1.74K$141.29−$245.8K−9.2%17.3K after2 lots10b5-1
Feb 2, 2024 (view filing)Jan 31-Feb 12 daysDelaet IngridChief Regulatory OfficerSSale−1.04K$140.65−$147.0K−13.2%6.87K after2 lots10b5-1
Feb 2, 2024 (view filing)Jan 312 daysGano KyleChief Business Development OffSSale−1.54K$140.70−$216.8K−1.2%131.6K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysGorman Kevin CharlesChief Executive OfficerSSale−2.71K$140.69−$380.8K−0.5%502.2K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysLippoldt DarinChief Legal OfficerSSale−1.25K$140.65−$175.8K−3.3%37.0K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysOnyia JudeChief Scientific OfficerSSale−126$141.94−$17.9K−1.1%11.8K after10b5-1
Feb 2, 2024 (view filing)Jan 312 daysRoberts EiryChief Medical OfficerSSale−1.46K$140.79−$205.1K−6.5%20.8K after10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysAbernethy MattChief Financial OfficerSSale−2.26K$138.73−$313.5K−6.9%30.3K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysBenevich EricChief Commercial OfficerSSale−2.26K$138.68−$313.4K−5.4%39.6K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysGano KyleChief Business Development OffSSale−2.58K$139.16−$359.0K−1.9%134.0K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysGorman Kevin CharlesChief Executive OfficerSSale−5.31K$138.74−$737.3K−1.0%507.0K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysLippoldt DarinChief Legal OfficerSSale−1.95K$138.47−$270.3K−4.8%38.8K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysRoberts EiryChief Medical OfficerSSale−2.10K$138.49−$291.0K−8.5%22.7K after2 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysCooke JulieChief Human Resources OfficerSSale−2.54K$138.61−$352.6K−12.8%17.3K after4 lots10b5-1
Feb 8, 2024 (view filing)Feb 6-82 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.78K$137.09−$244.6K−26.7%4.89K after4 lots10b5-1
Feb 15, 2024 (view filing)Feb 132 daysAbernethy MattChief Financial OfficerSSale−1.35K$132.85−$179.6K−4.1%31.5K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysBenevich EricChief Commercial OfficerSSale−1.10K$133.01−$146.0K−2.6%40.6K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysBoyer David W.Chief Corp. Affairs OfficerSSale−1.81K$133.08−$241.0K−27.0%4.89K after2 lots10b5-1
Feb 15, 2024 (view filing)Feb 132 daysCooke JulieChief Human Resources OfficerSSale−796$133.04−$105.9K−4.2%18.0K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysDelaet IngridChief Regulatory OfficerSSale−716$133.03−$95.2K−8.7%7.51K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysGano KyleChief Business Development OffSSale−1.35K$132.89−$179.7K−1.0%135.2K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysGorman Kevin CharlesChief Executive OfficerSSale−2.83K$133.02−$376.7K−0.5%514.6K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysLippoldt DarinChief Legal OfficerSSale−1.10K$132.99−$146.0K−2.7%39.7K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysOnyia JudeChief Scientific OfficerSSale−1.43K$132.94−$190.4K−9.8%13.1K after10b5-1
Feb 15, 2024 (view filing)Feb 132 daysRoberts EiryChief Medical OfficerSSale−1.11K$132.96−$148.1K−4.5%23.7K after10b5-1
Feb 22, 2024 (view filing)Feb 202 daysPops Richard FDirectorSSale−15.0K$132.47−$1.99M−33.7%29.5K after10b5-1
Feb 29, 2024 (view filing)Feb 272 daysNorwalk Leslie VDirectorSSale−8.00K$135.67−$1.09M−100.0%0 after10b5-1
Feb 29, 2024 (view filing)Feb 281 dayBenevich EricChief Commercial OfficerSSale−75.0K$134.69−$10.1M−64.9%40.6K after2 lots10b5-1
Feb 29, 2024 (view filing)Feb 28-291 dayDelaet IngridChief Regulatory OfficerSSale−6.82K$135.34−$922.6K−47.6%7.51K after4 lots10b5-1
Mar 12, 2024 (view filing)Mar 8-114 daysDelaet IngridChief Regulatory OfficerSSale−2.00K$140.03−$280.1K−21.0%7.51K after2 lots10b5-1
Mar 12, 2024 (view filing)Mar 8-114 daysPops Richard FDirectorSSale−1.80K$140.05−$252.1K−5.7%29.5K after2 lots10b5-1
Mar 15, 2024 (view filing)Mar 132 daysDelaet IngridChief Regulatory OfficerSSale−3.00K$140.14−$420.4K−28.6%7.51K after10b5-1
Mar 15, 2024 (view filing)Mar 132 daysPops Richard FDirectorSSale−23.2K$140.33−$3.26M−44.0%29.5K after10b5-1
Mar 15, 2024 (view filing)Mar 141 dayMorrow George JDirectorSSale−40.0K$139.42−$5.58M−100.0%0 after2 lots10b5-1
Mar 15, 2024 (view filing)Mar 141 dayBenevich EricChief Commercial OfficerSSale−75.0K$139.38−$10.5M−64.8%40.8K after2 lots10b5-1
Mar 25, 2024 (view filing)Mar 214 daysDelaet IngridChief Regulatory OfficerSSale−5.00K$145.06−$725.3K−40.0%7.51K after10b5-1
Apr 3, 2024 (view filing)Apr 12 daysDelaet IngridChief Regulatory OfficerSSale−272$137.30−$37.3K−3.5%7.51K after10b5-1
Apr 17, 2024 (view filing)Apr 152 daysBenevich EricChief Commercial OfficerSSale−19.8K$133.36−$2.64M−32.7%40.8K after2 lots10b5-1
May 8, 2024 (view filing)May 62 daysDelaet IngridChief Regulatory OfficerSSale−273$140.55−$38.4K−3.5%7.51K after10b5-1
May 16, 2024 (view filing)May 14-152 daysAbernethy MattChief Financial OfficerSSale−30.0K$137.95−$4.14M−48.8%31.5K after2 lots10b5-1
May 16, 2024 (view filing)May 142 daysLyons Gary ADirectorSSale−12.5K$135.63−$1.70M−9.7%116.9K after10b5-1
May 21, 2024 (view filing)May 174 daysNorwalk Leslie VDirectorSSale−1.11K$141.82−$156.9K−52.7%994 after10b5-1
May 21, 2024 (view filing)May 174 daysPops Richard FDirectorSSale−2.10K$141.84−$297.9K−6.2%31.6K after10b5-1
May 21, 2024 (view filing)May 174 daysSharp ShaliniDirectorSSale−1.11K$141.90−$156.9K−52.7%994 after10b5-1
May 30, 2024 (view filing)May 291 daySherwin Stephen ADirectorSSale−40.0K$133.46−$5.34M−60.1%26.5K after2 lots10b5-1
Jun 4, 2024 (view filing)May 314 daysDelaet IngridChief Regulatory OfficerSSale−273$136.55−$37.3K−3.5%7.51K after10b5-1
Jul 2, 2024 (view filing)Jul 11 dayDelaet IngridChief Regulatory OfficerSSale−272$138.11−$37.6K−3.5%7.51K after10b5-1
Jul 2, 2024 (view filing)Jul 11 dayCooke JulieChief Human Resources OfficerSSale−10.0K$140.19−$1.40M−35.5%18.2K after10b5-1